Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen

Clinical Immunology

Volumn 136, Issue 2, 2010, Pages 174-187

  Tian, Chaorui ^a   Yuan, Xueli ^a   Jindra, Peter T ^a   Bagley, Jessamyn ^a   Sayegh, Mohamed H ^a   Iacomini, John ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

T cells; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN; CYTOKINE; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CELL SURVIVAL; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; HEART GRAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GRAFT REJECTION; HEART TRANSPLANTATION; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 77954313560     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.04.012     Document Type: Article

References (66)

1. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
2. Kappler J.W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987, 49:273-280.
3. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 2007, 8:191-197.
4. Billingham R.E., Brent L., Medawar P.B. Activity acquired tolerance of foreign cells. Nature 1953, 172:603-606.
5. Slavin S., Strober S., Fuks Z., Kaplan H.S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J. Exp. Med. 1977, 146:34-48.
6. Ildstad S.T., Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984, 307:168-170.
7. Wekerle T., Sykes M. Mixed chimerism and transplantation tolerance. Annu. Rev. Med. 2001, 52:353-370.
8. Socie G., Blazar B.R. Acute graft-versus-host disease: from the bench to the bedside. Blood 2009, 114:4327-4336.
9. Daly A., McAfee S., Dey B., Colby C., Schulte L., Yeap B., Sackstein R., Tarbell N.J., Sachs D., Sykes M., Spitzer T.R. Nonmyeloablative bone marrow transplantation: infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol. Blood Marrow Transplant. 2003, 9:373-382.
10. Parkman R., Weinberg K.I. Immunological reconstitution following bone marrow transplantation. Immunol. Rev. 1997, 157:73-78.
11. Williams M.A., Adams A.B., Walsh M.B., Shirasugi N., Onami T.M., Pearson T.C., Ahmed R., Larsen C.P. Primary and secondary immunocompetence in mixed allogeneic chimeras. J. Immunol. 2003, 170:2382-2389.
12. Clift R.A., Storb R. Histoincompatible bone marrow transplants in humans. Annu. Rev. Immunol. 1987, 5:43-64.
13. Welniak L.A., Blazar B.R., Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol. 2007, 25:139-170.
14. Knechtle S.J. Knowledge about transplantation tolerance gained in primates. Curr. Opin. Immunol. 2000, 12:552-556.
15. Fehr T., Sykes M. Tolerance induction in clinical transplantation. Transpl. Immunol. 2004, 13:117-130.
16. Toh H.C., Spitzer T.R., Preffer F., Alexander S.I., McAfee S., Dombkowski D., Clark J.S., Colby C., Saidman S., Sackstein R., Sykes M. Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplant. Cytokines Cell. Mol. Ther. 2002, 7:43-47.
17. Dey B.R., McAfee S., Colby C., Cieply K., Caron M., Saidman S., Preffer F., Shaffer J., Tarbell N., Sackstein R., Sachs D., Sykes M., Spitzer T.R. Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br. J. Haematol. 2005, 128:351-359.
18. Zinkernagel R.M., Althage A., Callahan G., Welsh R.M. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J. Immunol. 1980, 124:2356-2365.
19. Russell P.S., Chase C.M., Sykes M., Ito H., Shaffer J., Colvin R.B. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J. Immunol. 2001, 167:5731-5740.
20. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 2004, 4:378-383.
21. Womer K.L., Lee R.S., Madsen J.C., Sayegh M.H. Tolerance and chronic rejection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:727-738.
22. Wood K., Sachs D.H. Chimerism and transplantation tolerance: cause and effect. Immunol. Today 1996, 17:584-587. discussion 588.
23. Ferguson T.A., Kazama H. Signals from dying cells: tolerance induction by the dendritic cell. Immunol. Res. 2005, 32:99-108.
24. Enk A.H. Dendritic cells in tolerance induction. Immunol. Lett. 2005, 99:8-11.
25. Lin H.H., Faunce D.E., Stacey M., Terajewicz A., Nakamura T., Zhang-Hoover J., Kerley M., Mucenski M.L., Gordon S., Stein-Streilein J. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J. Exp. Med. 2005, 201:1615-1625.
26. Jenkinson E.J., Jhittay P., Kingston R., Owen J.J. Studies of the role of the thymic environment in the induction of tolerance to MHC antigens. Transplantation 1985, 39:331-333.
27. Gao E.K., Lo D., Sprent J. Strong T cell tolerance in parent-F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy. J. Exp. Med. 1990, 171:1101-1121.
28. Tomita Y., Khan A., Sykes M. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 1996, 61:477-485.
29. Shimonkevitz R.P., Bevan M.J. Split tolerance induced by the intrathymic adoptive transfer of thymocyte stem cells. J. Exp. Med. 1988, 168:143-156.
30. Schulz R., Mellor A.L. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment. J. Exp. Med. 1996, 184:1573-1578.
31. Weissman I.L., Jerabek L., Greenspan S. Tolerance and the H-Y antigen: requirement for male T cells, but not B cells, to induce tolerance in neonatal female mice. Transplantation 1984, 37:3-6.
32. Umemura A., Morita H., Li X.C., Tahan S., Monaco A.P., Maki T. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation. J. Immunol. 2001, 167:3043-3048.
33. Anderson C.C., Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat. Med. 2001, 7:80-87.
34. Bagley J., Tian C., Iacomini J. New approaches to the prevention of organ allograft rejection and tolerance induction. Transplantation 2007, 84:S38-S41.
35. Tian C., Bagley J., Iacomini J. Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy. J. Immunol. 2002, 169:3771-3776.
36. Tian C., Bagley J., Forman D., Iacomini J. Induction of central tolerance by mature T cells. J. Immunol. 2004, 173:7217-7222.
37. Tian C., Yuan X., Bagley J., Blazar B.R., Sayegh M.H., Iacomini J. Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells. Clin. Immunol. 2008, 127:130-137.
38. Sarmiento M., Glasebrook A.L., Fitch F.W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 1980, 125:2665-2672.
39. Dialynas D.P., Quan Z.S., Wall K.A., Pierres A., Quintans J., Loken M.R., Pierres M., Fitch F.W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 1983, 131:2445-2451.
40. Bagley J., Tian C., Sachs D.H., Iacomini J. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood 2002, 99:4394-4399.
41. Noelle R.J., Roy M., Shepherd D.M., Stamenkovic I., Ledbetter J.A., Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6550-6554.
42. Corry R.J., Winn H.J., Russell P.S. Heart transplantation in congenic strains of mice. Transplant. Proc. 1973, 5:733-735.
43. Tian C., Bagley J., Cretin N., Seth N., Wucherpfennig K.W., Iacomini J. Prevention of type 1 diabetes by gene therapy. J. Clin. Invest. 2004, 114:969-978.
44. Lee R.S., Yamada K., Houser S.L., Womer K.L., Maloney M.E., Rose H.S., Sayegh M.H., Madsen J.C. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3276-3281.
45. Acha-Orbea H., MacDonald H.R. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 1995, 13:459-486.
46. van Bekkum D.W. Conditioning regimens for marrow grafting. Semin. Hematol. 1984, 21:81-90.
47. Ferrara J.L., Cooke K.R., Teshima T. The pathophysiology of acute graft-versus-host disease. Int. J. Hematol. 2003, 78:181-187.
48. Tian C., Bagley J., Iacomini J. Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion. Am. J. Transplant. 2007, 7:1934-1941.
49. Sho M., Kishimoto K., Harada H., Livak M., Sanchez-Fueyo A., Yamada A., Zheng X.X., Strom T.B., Basadonna G.P., Sayegh M.H., Rothstein D.M. Requirements for induction and maintenance of peripheral tolerance in stringent allograft models. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13230-13235.
50. Rao D.A., Pober J.S. Endothelial injury, alarmins, and allograft rejection. Crit. Rev. Immunol. 2008, 28:229-248.
51. Vamvakopoulos J.E., Taylor C.J., Green C., McNeil K., Wallwork J., Goodman R., Metcalf S.M. Interleukin 1 and chronic rejection: possible genetic links in human heart allografts. Am. J. Transplant. 2002, 2:76-83.
52. Lattmann T., Hein M., Horber S., Ortmann J., Teixeira M.M., Souza D.G., Haas E., Tornillo L., Munter K., Vetter W., Barton M. Activation of pro-inflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling. Am. J. Transplant. 2005, 5:1042-1049.
53. Booth A.J., Csencsits-Smith K., Wood S.C., Lu G., Lipson K.E., Bishop D.K. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am. J. Transplant. 2009, 10:220-230.
54. Diaz J.A., Booth A.J., Lu G., Wood S.C., Pinsky D.J., Bishop D.K. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am. J. Transplant. 2009, 9:1773-1783.
55. Tian C., Bagley J., Iacomini J. Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells. Am. J. Transplant. 2006, 6:2202-2207.
56. Webb S.R., Sprent J. Induction of neonatal tolerance to Mlsa antigens by CD8+ T cells. Science 1990, 248:1643-1646.
57. Waanders G.A., Lees R.K., Held W., MacDonald H.R. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets. Eur. J. Immunol. 1995, 25:2632-2637.
58. Schooten E., Klous P., van den Elsen P.J., Holling T.M. Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region. Immunogenetics 2005, 57:795-799.
59. Beutner U., McLellan B., Kraus E., Huber B.T. Lack of MMTV superantigen presentation in MHC class II-deficient mice. Cell. Immunol. 1996, 168:141-147.
60. Zhang H., Chua K.S., Guimond M., Kapoor V., Brown M.V., Fleisher T.A., Long L.M., Bernstein D., Hill B.J., Douek D.C., Berzofsky J.A., Carter C.S., Read E.J., Helman L.J., Mackall C.L. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med. 2005, 11:1238-1243.
61. Kang E.S., Iacomini J. Induction of central deletional T cell tolerance by gene therapy. J. Immunol. 2002, 169:1930-1935.
62. Forman D., Kang E.S., Tian C., Paez-Cortez J., Iacomini J. Induction of alloreactive CD4 T cell tolerance in molecular chimeras: a possible role for regulatory T cells. J. Immunol. 2006, 176:3410-3416.
63. Forman D., Tian C., Iacomini J. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy. Mol. Ther. 2005, 12:353-359.
64. Khan A., Tomita Y., Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996, 62:380-387.
65. Kurtz J., Shaffer J., Lie A., Anosova N., Benichou G., Sykes M. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. Blood 2004, 103:4336-4343.
66. Domenig C., Sanchez-Fueyo A., Kurtz J., Alexopoulos S.P., Mariat C., Sykes M., Strom T.B., Zheng X.X. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J. Immunol. 2005, 175:51-60.